1Ishitani M. HBV vaccination and liver transplantation for hepatitis B: winning by recruiting from within? Liver Transpl, 2000, 6: 659-661. 被引量：1
2BenAri Z, Shmueli D, Shapira Z, et al. Loss of serum HBsAg after interferon-α therapy in liver transplant patients with recurrent hepatitis-B infection. Liver Transpl Surg, 1997, 3: 394-397. 被引量：1
3Bismuth H, Majno PE, Adam R, et al. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis, 1999, 19: 311-322. 被引量：1
4Robert P, Jorge R, Jules D, et al. Molticenter study of Lamivudine therapy for hepatitis B after liver transplantation. Hepatoloty, 1999, 29: 1581-1586. 被引量：1
5Reddy KS, Johnston TD, Putnam LA, et al. Piggyback technique and selective use of veno-venous bypass in adult orthotopic liver transplantation. Clin Transplant, 2000, 14: 370-374. 被引量：1
6Rossi G, Langer M, Maggi U, et al. Veno-venous bypass versus no bypass in orthotopic liver transplantation: hemodynamic, metabolic, and renal data. Transplant Proc, 1998, 30: 1871-1873. 被引量：1
7Krawczyk M, Nyckowski P, Zieniewicz K, et al. Biliary complications following liver transplantation. Transplant Proc, 2000, 32: 1429-1431. 被引量：1
8Eid A, Lyass M, Venturero M, et al. Vascular complications post orthotopic liver transplantation. Transplant Proc, 1999,31: 1903-1904. 被引量：1
9Oike F, Uryuhara K, Otsuka M, et al. Simplified technique of orthotopic liver transplantation in pigs. Transplantation, 2001, 71: 328-331. 被引量：1
10Hesse UJ, Berrevoet F, Troisi R, et al. Hepato-venous reconstruction in orthotopic liver transplantation with preservation of the recipients' inferior vena cava and veno-venous bypass. Langenbecks Arch Surg, 2000, 385: 350-356. 被引量：1
1Balzarini J, Hao Z, Herdewijn P, et al. Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound [J]. Proc Natl Acad Sci USA, 1991; 88(4): 1499 被引量：1
2Malkan G, Cattral MS, Humar A, et al. Lamivudine for hepatitis B in liver transplantation: a single-center experience [J].Transplantation, 2000; 69(7): 1403 被引量：1
3Manns MP. Famcidovir treatment of hepatitis B infection follwing liver transplantation: a long-term, multi-centre study [J].Transplant Inject Dis, 2001; 3(1): 16 被引量：1
4Han SH, Kinkhabwala M, Martin P, et al. Resolution of recurrent hepatitis B in two liver transplant recipients treated with famciclovir [J]. Am J Gastroenterol, 1998; 93(11) : 2245 被引量：1
5Rayes N, Seehofer D, Hopf U, et al. Comparison of famciclovir and lamivudine in the long term treatment of hepatitis B infection after liver transplantation [J]. Transplantation, 2001; 71(1):96 被引量：1
6Angus PW. Review: hepatitis B and liver transplantation [ J]. J Gastroenterol Hepatol, 1997; 12(3): 217 被引量：1
7Heijtink RA, De Wilde GA, Kruining J, et al. Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection [J]. Antiviral Res, 1993;21(2): 141 被引量：1
8Perrillo R, Schiff E, Yoshida E, et al. Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants [J].Hepatology, 2000; 32(1) : 129 被引量：1
9Samuel D, Feray C, Bismuth H. Hepatitis viruses and liver transplantation [J]. J Gastroenterol Hepatol, 1997; 12 (9-10): S335 被引量：1
10Samuel D, Muller R, Alexander G, et al. Liver transplantation in European patients with the hepatitis B surface antigen [J]. N Engl J Med, 1993; 329(25): 1842 被引量：1
